Can Adjuvant Pembrolizumab Improve Outcomes in Triple-Negative Breast Cancer?
(MedPage Today) -- In this exclusive MedPage Today video, Rena Callahan, MD, of UCLA Health Santa Clarita Cancer Care in California, previews findings from the phase III SWOG-S1418/NRG Oncology BR006 trial of adjuvant pembrolizumab (Keytruda) in...
We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.